Paul O'Byrne

Paul O'Byrne

McMaster University

H-index: 126

North America-Canada

About Paul O'Byrne

Paul O'Byrne, With an exceptional h-index of 126 and a recent h-index of 56 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Respirology, Asthma, Allergy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Asthma remission

Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma

Dupilumab Add-on to Medium-dose Inhaled Corticosteroid (ICS) Increases Odds of Asthma Control and Reduces FeNO Compared With Placebo Add-on to High-dose ICS

Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging (CLSA)(vol 219 …

Corrigendum to" Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging …

Remissão da asma

Development of the McMaster Cough Severity Questionnaire (MCSQ): A Cough Severity Instrument for Patients With Chronic Cough

Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS

Paul O'Byrne Information

University

Position

Professor

Citations(all)

69855

Citations(since 2020)

15933

Cited By

59572

hIndex(all)

126

hIndex(since 2020)

56

i10Index(all)

477

i10Index(since 2020)

237

Email

University Profile Page

McMaster University

Google Scholar

View Google Scholar Profile

Paul O'Byrne Skills & Research Interests

Respirology

Asthma

Allergy

Top articles of Paul O'Byrne

Title

Journal

Author(s)

Publication Date

Asthma remission

Paul M O’Byrne

2024/3/22

Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma

American Journal of Respiratory and Critical Care Medicine

Xiaotian Ju

Akimichi Nagashima

Anna Dvorkin-Gheva

Jennifer Wattie

Karen Howie

...

2024/4/10

Dupilumab Add-on to Medium-dose Inhaled Corticosteroid (ICS) Increases Odds of Asthma Control and Reduces FeNO Compared With Placebo Add-on to High-dose ICS

W Busse

M Castro

NL Lugogo

PM O’Byrne

LB Bacharier

...

2024/5

Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging (CLSA)(vol 219 …

Respiratory Medicine

Imran Satia

Alexandra J Mayhew

Nazmul Sohel

Om Kurmi

Kieran J Killian

...

2023/11/1

Corrigendum to" Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging …

Respiratory medicine

Imran Satia

Alexandra J Mayhew

Nazmul Sohel

Om Kurmi

Kieran J Killian

...

2024/3/1

Remissão da asma

Paul M O’Byrne

2024/3/22

Development of the McMaster Cough Severity Questionnaire (MCSQ): A Cough Severity Instrument for Patients With Chronic Cough

E Kum

G Guyatt

R Abdulqawi

P Dicpinigaitis

L Dupont

...

2024/5

Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS

Journal of Allergy and Clinical Immunology

William Busse

Mario Castro

Njira Lugogo

Paul O'Byrne

Leonard Bacharier

...

2024/2/1

Eosinophil Plasticity and Diversity: Proceedings of the 2023 International Eosinophil Society Symposium

Judah A Denburg

Paul M O’Byrne

Gail M Gauvreau

2024/4/16

Development of an inhaled anti-TSLP therapy for asthma

Paul M O'Byrne

Reynold A Panettieri Jr

Christian Taube

Caterina Brindicci

Margaret Fleming

...

2023/2/1

An Official American Thoracic Society Research Statement: Executive Summary.

American Journal of Respiratory & Critical Care Medicine

ARJUN MOHAN

NJIRA L LUGOGO

NICOLA A HANANIA

KAHARU SUMINO

PRAVEEN AKUTHOTA

...

2023/6/1

Relationship between subjective cough outcomes and activity impairment in patients with chronic cough

Mustafaa Wahab

Chaoqun Cherry Xu

Elena Kum

Nermin Diab

Danica Brister

...

2023/9/9

Protein expression of SARS-CoV-2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challenge

Allergy

Christiane E Whetstone

Maral Ranjbar

Ruth P Cusack

Dhuha Al-Sajee

Hafsa Omer

...

2023/11

Sounding the alarmins—The role of alarmin cytokines in asthma

Gail M Gauvreau

Celine Bergeron

Louis‐Philippe Boulet

Donald W Cockcroft

Andréanne Côté

...

2023/2

Questions in mild asthma: an official American Thoracic Society research statement

American journal of respiratory and critical care medicine

Arjun Mohan

Njira L Lugogo

Nicola A Hanania

Helen K Reddel

Praveen Akuthota

...

2023/6/1

The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity

PLoS One

Eldar Priel

Nermin Diab

Matthew Patel

Mustafaa Wahab

Andreas Freitag

...

2023/8/8

Demographics and subjective cough outcomes of guideline-based treatment in the McMaster Cough Clinic.

Mustafaa Wahab

Elena Kum

Nermin Diab

Danica Brister

Caitlin Obminski

...

2023/9/9

Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids

Clinical & Experimental Allergy

Rebecca N Bauer

Yanqing Xie

Suzanne Beaudin

Lesley Wiltshire

Jennifer Wattie

...

2023/11

Benralizumab Normalizes Sputum Eosinophilia in Severe Asthma Uncontrolled by Anti–IL-5 Antibodies: A Single-Blind, Placebo-controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine

Manali Mukherjee

Chynna Huang

Carmen Venegas-Garrido

Kayla Zhang

Anurag Bhalla

...

2023/12/15

Non-T2 cytokines post Benralizumab associate with residual symptoms

Manali Mukherjee

Chynna Huang

Kayla Zhang

Xiaotian Ju

Melanie Kjarsgaard

...

2023/9/9

See List of Professors in Paul O'Byrne University(McMaster University)